By Scott Gottlieb (Original source The Hill)
“During his Senate confirmation hearing in April 2017, Dr. Scott Gottlieb committed himself to “the gold standard of safety and efficacy.”
Over the past two years as head of the Food and Drug Administration (FDA), Commissioner Gottlieb has made good on that promise, and his tenure has been a model for future FDA chiefs.
To his great credit and the benefit of consumers, Gottlieb, whose tenure at the agency ended recently, pursued policies that encouraged competition and choice.
In fall 2016, months before his appointment as FDA chief, Gottlieb foreshadowed his approach to the FDA in testimony at a Senate hearing on the EpiPen price scandal.”
Click here to see more
Erika Ayers Badan: What Your Work Clothes Really Say About You
In this episode of WORK, Erika dives into how personal style shapes professional presence with Jennifer Heinen, a leading fashion psychologist and creator of the Style‑Mind…
Thought Leader: Erika Ayers Badan
David Frum: Iran Strikes, MAGA Civil War, and Tariff Losers
David Frum joins Jamie Weinstein to discuss President Trump’s Iran strikes, the internal MAGA war over foreign policy, and the trade tariffs. The Agenda: —The…
Thought Leader: David Frum
Peter Goodman: Tariffs Could Cost U.S. Jobs
The experience of a company in the textile business illustrates how the trade war could force some industries to shift production out of the United…
Thought Leader: Peter Goodman
